924
Participants
Start Date
October 31, 2011
Primary Completion Date
July 31, 2012
Study Completion Date
August 31, 2012
desvenlafaxine succinate sustained-release 50 mg/day
50 mg tablets of DVS SR taken orally once daily for 8 weeks; 1 week of placebo taper
desvenlafaxine succinate sustained-release 100 mg/day
100 mg tablets of DVS SR taken orally once daily for 8 weeks (which includes 1 week of titration at 50 mg/day); 1 week of taper at 50 mg/day
placebo
50 mg and 100 mg placebo matching tablets taken orally once daily for 8 weeks; 1 week of placebo taper
Eastside Comprehensive Medical Center, LLC, New York
Medical and Behavioral Health Research Pc, New York
Social Psychiatry Research Institute, Brooklyn
Neurobehavioral Research, Inc, Cedarhurst
Lehigh Center for Clinical Research, Allentown
Suburban Research Associates, Media
CRI Worldwide, LLC, Philadelphia
Pharmasite Research Inc, Baltimore
Carolina Clinical Research Services, Columbia
Carman Research, Smyrna
Atlanta Center for Medical Research, Atlanta
Comprehensive NeuroScience, Incorporated, Atlanta
Clinical Neuroscience Solutions Incorporated, Jacksonville
Florida Clinical Research Center, LLC, Maitland
Janus Center for Psychiatric Research, West Palm Beach
Comprehensive NeuroScience, Inc., St. Petersburg
Accurate Clinical Trials, Inc., Kissimmee
NorthCoast Clinical Trials Inc., Beachwood
Neuro-Behavioral Clinical Research, Inc., Canton
Patient Priority Clinical Sites, LLC, Cincinnati
Midwest Clinical Research Center, Dayton
Prairie St. Johns Clinic - Fargo, Fargo
Odyssey Research, Fargo
Plains Medical Clinic, Fargo
Capstone Clinical Research, Libertyville
Joliet Center for Clinical Research, Joliet
American Medical Research, Inc., Oak Brook
AMR-Baber Research Inc., Naperville
Midwest Research Group, Saint Charles
Psychiatric Associates, Overland Park
Via Christi Research, Wichita
Heartland Pharma Development, North Platte
Arkansas Psychiatric Clinic Clinical Research Trials, P.A., Little Rock
Cutting Edge Research Group, Oklahoma City
KRK Medical Research, Dallas
FutureSearch Trials of Dallas, Dallas
Red Oak Psychiatry Associates, PA, Houston
FutureSearch Trials, Austin
Radiant Research, Inc., Murray
Dedicated Clinical Research, Phoenix
Deidcated Clinical Research, Phoenix
Southwestern Research, Incorporated, Beverly Hills
Collaborative Neuroscience Network, Inc. South Bay, Torrance
Pacific Clinical Research Medical Group, Arcadia
Pasadena Research Institute, LLC, Pasadena
California Neuroscience Research Medical Group, Inc, Sherman Oaks
Pacific Clinical Research Medical Group, Upland
Synergy Clinical Research Center, National City
Synergy Clinical Research of Escondido, Escondido
Affiliated Research Institute, San Diego
Clinical Innovations, Inc., San Diego
Clinical Innovations, Inc., Riverside
Viking Clinical Research Center, Temecula
Clinical Innovations, Inc., Costa Mesa
Pacific Research Partners, Oakland
Oregon Center for Clinical Investigations, Inc., Portland
Summit Research Network (Oregon), Inc., Portland
Eastside Therapeutic Resource, Kirkland
Summit Research Network (Seattle) LLC, Seattle
CRI Worldwide, LLC, Marlton
Lincoln Research, Lincoln
Lead Sponsor
Pfizer
INDUSTRY